BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34800515)

  • 21. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients.
    Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
    Eur J Cancer; 1998 Jul; 34(8):1193-7. PubMed ID: 9849478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma.
    Mäkinen LK; Atula T; Häyry V; Jouhi L; Datta N; Lehtonen S; Ahmed A; Mäkitie AA; Haglund C; Hagström J
    Oral Oncol; 2015 Jan; 51(1):96-102. PubMed ID: 25264223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
    Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
    Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
    Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
    Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluctuating role of antimicrobial peptide hCAP18/LL‑37 in oral tongue dysplasia and carcinoma.
    Vierthaler M; Rodrigues PC; Sundquist E; Siponen M; Salo T; Risteli M
    Oncol Rep; 2020 Jul; 44(1):325-338. PubMed ID: 32627035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophages modulate migration and invasion of human tongue squamous cell carcinoma.
    Pirilä E; Väyrynen O; Sundquist E; Päkkilä K; Nyberg P; Nurmenniemi S; Pääkkönen V; Pesonen P; Dayan D; Vered M; Uhlin-Hansen L; Salo T
    PLoS One; 2015; 10(3):e0120895. PubMed ID: 25811194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
    Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
    Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro.
    Bitu CC; Kauppila JH; Bufalino A; Nurmenniemi S; Teppo S; Keinänen M; Vilen ST; Lehenkari P; Nyberg P; Coletta RD; Salo T
    PLoS One; 2013; 8(8):e70925. PubMed ID: 23951042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol depletion affects caveolin-1 expression, migration and invasion of oral tongue squamous cell carcinoma cell lines.
    Nascimento RB; Risteli M; Paiva KBS; Juurikka K; Rodrigues MFSD; Salo TA; Xavier FCA
    Arch Oral Biol; 2023 Jun; 150():105675. PubMed ID: 36989864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
    Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
    Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
    Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
    Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The expression and clinical significance of BATF2 in oral tongue squamous cell carcinoma].
    Wen H; Tang J; Liu B; Sun C
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jan; 50(1):13-7. PubMed ID: 25779069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma.
    Sá MC; Conceição TS; de Moura Santos E; de Morais EF; Galvão HC; de Almeida Freitas R
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):893-902. PubMed ID: 31828418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
    Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
    Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
    Almangush A; Hagström J; Haglund C; Kowalski LP; Coletta RD; Mäkitie AA; Salo T; Leivo I
    BMC Cancer; 2024 Feb; 24(1):213. PubMed ID: 38360653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao E; Han D; Yu Z; Fan E; Li Y; Zhou Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):599-602. PubMed ID: 15515548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
    Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
    Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF-2 and FGFR-1 might be independent prognostic factors in oral tongue squamous cell carcinoma.
    Mariz BALA; Soares CD; de Carvalho MGF; Jorge-Júnior J
    Histopathology; 2019 Jan; 74(2):311-320. PubMed ID: 30129658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.